Tandem Diabetes Care (TNDM) EBT Margin (2013 - 2026)
Tandem Diabetes Care's (TNDM) quarterly EBT Margin came in at 8.05% in Q1 2026, up 4404.0% YoY from 0.18% in Q1 2025, and down 594.38% on a QoQ basis from 1.63% in Q4 2025.
Tandem Diabetes Care (TNDM) EBT Margin (2013 - 2026) Analysis & Trends
Tandem Diabetes Care (TNDM) has 14 years of EBT Margin data on file, last reported at 8.05% in Q1 2026.
- Quarterly EBT Margin rose 4404.0% year-over-year to 8.05% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 9.54% (up 821.0% YoY) and the FY2025 annual result came in at 19.74%, down 997.0% from the prior year.
- EBT Margin declined to 8.05% in Q1 2026, from 1.63% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 1.63% in Q4 2025 to a low of 72.97% in Q1 2023.
- A 5-year average of 17.96% and a median of 13.4% in 2024 frame the typical range for EBT Margin.
- Annual changes were most pronounced in 2023 — EBT Margin plunged 6363 bps — and 2024, when it jumped 5235 bps.
- Tracing TNDM's EBT Margin over 5 years: stood at 7.33% in 2022, then sank by 117 bps to 15.91% in 2023, then jumped by 100 bps to 0.01% in 2024, then jumped by 28663 bps to 1.63% in 2025, then plunged by 594 bps to 8.05% in 2026.
- The last three EBT Margin figures came in at 8.05% (Q1 2026), 1.63% (Q4 2025), and 10.09% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.19 Bn | 194.59 Bn | 7.27 Bn | 12.10% |
| 2 | Stryker | 129.95 Bn | 126.47 Bn | 4.50 Bn | 23.74% |
| 3 | Medtronic | 120.06 Bn | 110.84 Bn | 6.41 Bn | 18.70% |
| 4 | Boston Scientific | 74.14 Bn | 73.60 Bn | 3.85 Bn | 19.48% |
| 5 | Edwards Lifesciences | 52.74 Bn | 48.49 Bn | 1.35 Bn | 29.86% |
| 6 | Dexcom | 34.60 Bn | 32.65 Bn | 830.00 Mn | 24.27% |
| 7 | GE HealthCare Technologies | 34.20 Bn | 32.10 Bn | 2.18 Bn | 13.09% |
| 8 | Koninklijke Philips | 26.46 Bn | 23.13 Bn | 4.55 Bn | 8.91% |
| 9 | Steris | 23.25 Bn | 22.77 Bn | 684.20 Mn | 18.32% |
| 10 | Tandem Diabetes Care | 1.56 Bn | 1.11 Bn | 144.78 Mn | -8.13% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -8.13% |
| Mar 31, 2026 | -8.05% |
| Dec 31, 2025 | 1.63% |
| Sep 30, 2025 | -10.09% |
| Jun 30, 2025 | -23.98% |
| Mar 31, 2025 | -52.09% |
| Dec 31, 2024 | 0.01% |
| Sep 30, 2024 | -9.27% |
| Jun 30, 2024 | -13.40% |
| Mar 31, 2024 | -20.62% |
| Dec 31, 2023 | -15.91% |
| Sep 30, 2023 | -16.55% |
| Jun 30, 2023 | -17.66% |
| Mar 31, 2023 | -72.97% |
| Dec 31, 2022 | -7.33% |
| Sep 30, 2022 | -23.15% |
| Jun 30, 2022 | -6.47% |
| Mar 31, 2022 | -9.35% |
| Dec 31, 2021 | 5.29% |
| Sep 30, 2021 | 3.23% |